Tinea capitis: Ringworm of the scalp

Mycoses

Volumn 50, Issue 3, 2007, Pages 218-226

  Seebacher, C ^a,b   Abeck, D ^b   Brasch, J ^b   Cornely, O ^b   Daeschlein, G ^b   Effendy, I ^b   Ginter Hanselmayer, G ^b   Haake, N ^b   Hamm, G ^b   Hipler, Ch ^b   Hof, H ^b   Korting, H C ^b   Kramer, A ^b   Mayser, P ^b   Ruhnke, M ^b   Schlacke, K H ^b   Tietz, H J ^b  

^a German Hospital Hygiene Society ^*  (Germany)

^b German Dermatology Society   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALLYLAMINE DERIVATIVE; AMIADA; ANTIFUNGAL AGENT; CICLOPIROXOLAMINE; CLOTRIMAZOLE; DERM; DERMATIN; DERMGEL; FLUCONAZOLE; FUNAZUL; GRISEOFULVIN; HEXAL; ISIS; ITRACOL; ITRACONAZOLE; MYCONORMIN; OCTOSAN; ONYMAX; POVIDONE IODINE; PYRROLE DERIVATIVE; RATIOPHARM; SANDOZ; SEBIPROX; SELENIUM SULFIDE; STADA; TERBIGALEN; TERBINAFINE; TOLCICLATE; TOLNAFTATE; UNCLASSIFIED DRUG; WINTHROP;

CLINICAL FEATURE; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; DISEASE TRANSMISSION; DRUG BLOOD LEVEL; FUNGUS CULTURE; HISTOLOGY; HOME CARE; HOSPITALIZATION; HUMAN; MICROSCOPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; REVIEW; TINEA CAPITIS; ULTRAVIOLET RADIATION;

ADOLESCENT; ADULT; ANIMALS; ANTIFUNGAL AGENTS; CATS; CHILD; CHILD, PRESCHOOL; CRICETINAE; DOGS; GUINEA PIGS; HUMANS; MICROSPORUM; RABBITS; TINEA CAPITIS; TRICHOPHYTON;

EID: 34247578669     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2006.01350.x     Document Type: Review

References (31)

1. Tietz HJ, Ulbricht HM, Sterry W. Tinea capitis in Deutschland - Ergebnisse einer epidemiologischen Analyse. Z Hautkr 1999 74 : 683 8.
2. Schwinn A, Ebert J, Bröcker E B. Frequency of T. rubrum in tinea capitis. Mycoses 1995 38 : 1 7.
3. Elewski BE. Tinea capitis: a current perspective. J Am Acad Dermatol 2000 42 : 1 20.
4. Möhrenschlager M, Seidl HP, Ginter-Hanselmayer G, Abeck D. Tinea capitis of childhood: incidence and pathogenetic role of Trichophyton tonsurans in central Europe. J Am Acad Dermatol 2001 45 : 320.
5. Otberg N, Tietz H-J, Henz BM, Haas N. Kerion due to Trichophyton mentagrophytes: responsiveness to fluconazole versus terbinafine in a child. Acta Derm Venereol 2001 81 : 444 5.
6. Haase G, Borg-von Zepelin M, Bernhardt H et al. Qualitätsstandards in der mikrobiologischen Diagnostik. Pilzinfektionen Teil I Präanalytik, Analytik (MiQ 14), Pilzinfektionen Teil II Spezielle Pilzdiagnostik (MiQ 15). München, Jena : Urban & Fischer, 2002.
7. Kefalidou S, Odia S, Gruseck E, Schmidt T, Ring J, Abeck D. Wood's light in Microsporum canis positive patients. Mycoses 1997 40 : 461 3.
8. Roberts BJ, Friedlander SF. Tinea capitis: a treatment update. Pediatric Ann 2005 34 : 191 200.
9. Gupta AK, Summerbell RC. Tinea capitis. Med Mycol 2000 38 : 255 87.
10. Gupta AK, Hofstader SLR, Adam P, Summerbell RC. Tinea capitis: an overview with emphasis on management. Pediatr Dermatol 1999 16 : 171 89.
11. López-Gómez S, Del Palazio A. Itraconazole versus griseofulvin in the treatment of tinea capitis: a double-blind randomized study in children. Int J Dermatol 1994 33 : 743 7.
12. Gupta AK, Adam P, Dlova N et al. Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazole. Pediatr Dermatol 2001 18 : 433 8.
13. Friedlander SF, Aly R, Krafchik B et al. Terbinafine in the treatment of Trichophyton tinea capitis: a randomized, double-blind, parallel-group, duration-finding study. Pediatrics 2002 109 : 602 7.
14. Gupta AK, Ginter G. Itraconazole is effective in the treatment of tinea capitis caused by Microsporum canis. Pediatr Dermatol 2001 18 : 519 22.
15. Ginter-Hanselmayer G, Smolle J, Gupta A. Itraconazole in the treatment of tinea capitis caused by Microsporum canis: experience in a large cohort. Pediatr Dermatol 2004 21 : 499 502.
16. Friedlander SF. Treating tinea capitis with terbinafine: latest findings. JEADV 2001 15 (Suppl. 2 99 (Abstract).
17. Dragos V, Lunder M. Lack of efficacy of 6-week treatment with oral terbinafine for tinea capitis due to Microsporum canis in children. Pediatr Dermatol 1997 14 : 46 8.
18. Fleece D, Gaughan JP, Aronoff SC. Griseofulvin versus terbinafin in treatment of tinea capitis: ameta-analysis of randomized, clinical trials. Pediatrics 2004 114 : 1312 5.
19. Dasghaib L, Azizzadeh M, Jafari P. Therapeutic options for the treatment of tinea capitis: griseofulvin versus fluconazole. J Dermatolog Treat 2005 16 : 43 6.
20. Wildfeuer A, Faergemann J, Laufen H et al. Bioavailability of fluconazole in the skin after oral medication. Mycoses 1994 37 : 127 30.
21. Gupta AK, Grooen K, Woestenborghs R, De Doncker P. Itraconazole pulse therapy is effective in the treatment of Majocchi's granuloma: a clinical and pharmacokinetic evaluation and implications for possible effectiveness in tinea capitis. Clin Exp Dermatol 1998 23 : 103 8.
22. Seebacher C. Grenzen der Kurzzeitbehandlung von Onychomykosen. Hautarzt 1998 49 : 705 8.
23. Tietz HJ, Sterry W. Antimykotika von A - Z Klinik und Pharmakologie auf einen Blick. Auflage, Stuttgart, NewYork : Thieme, 2006 : 4.
24. Higgins EM, Fuller LC, Smith CH. Guidelines for management of tinea capitis. Br J Dermatol 2000 143 : 53 8.
25. Kramer A, Daeschlein G, Kammerlander G et al. Konsensusempfehlung zur Auswahl von Wirkstoffen für die Wundantiseptik. Hyg Med 2004 5 : 147 57 Zfw 3 : 110 20.
26. Gupta AK, Ahmad I, Summerbell RC. Comparative efficacies of commonly used disinfectants and antifungal pharmaceutical spray preparations against dermatophytic fungi. Med Mycol 2001 39 : 321 8.
27. Aste N, Pau M, Biggio P. Tinea capitis in children in the district of Cagliari, Italy. Mycoses 1997 40 : 231 3.
28. Desinfektionsmittel-Liste des VAH, mhp Wiesbaden, 2006.
29. Montero-Gei F. Fluconazole in the treatment of tinea capitis. Intern J Dermatol 1998 37 : 870 3.
30. Faergemann J, Zehender H, Jones T, Maibach I. Terbinafine levels in serum, stratum corneum, dermis-epidermis (without stratum corneum), hair, sebum and eccrine sweat. Acta Derm Venereol (Stockh) 1991 71 : 322 6.
31. Cauwenbergh G, Degreef H, Heykants J, Woestenborghs R, Van Rooy P, Haeverans K. Pharmacokinetic profile of orally administered itraconazole in human skin. J Am Acad Dermatol 1988 18 : 263 8.